The Behavioral Economist
Contributor since: 2013
Latest Articles
MannKind: Seeing The Forest Through The Trees
3 Small Biotechs Worth Watching Over The Next 6 Months
Medifocus: A Biotechnology Nano-Cap Deserving Of More Attention
MannKind: Why The Short Argument Is Shortsighted
Paragon Shipping: Following Up With CEO Michael Bodouroglou
China Commercial Credit: Undervalued And Poised For Growth
Conatus Pharmaceuticals: An Undervalued Biotech With Intriguing Long-Term Potential
The Benefits Of Behavioral Finance, The Legacy Of Herbert Simon, And The Death Of Homo Economicus
Cell Therapeutics: Enticing To All, Convincing To None
Repligen: A Strong Investment For The Right Kind Of Investor
Verastem: Cancer May Have Met Its Match
Ziopharm: Attempting To Rise Again In A Crowded Space
Targacept: Traveling The Rocky Road To Redemption
A Behaviorist's Approach To Investment Strategy: Embrace Who You Are
OncoSec Medical Incorporated: Shareholder Patience Will Be Rewarded
Aradigm: A Biotechnology Micro-Cap With Asymmetrical Indicators And A Noteworthy Partner
USA Technologies: An Undervalued Opportunity In An Underappreciated Market
Aeolus Pharmaceuticals: A Biodefense Nano-Cap With Noteworthy Partners
Regado Biosciences: Seeking A Second First Impression
Sophiris Bio: Recent Price Action Offers An Attractive Entry Point
Evans Bancorp: A Community Institution Offering Steady Growth And Reliable Performance
Blue Earth: A Ground Floor Opportunity In Alternative And Renewable Energy
Immune Pharmaceuticals: A Speculative Biotech Option For The Patient Investor
WidePoint: 600 Million More Reasons To Invest
Kingstone: A 127-Year-Old Company With 20% Upside And A Sustainable Dividend
MediaShift: Worth A Look, In Spite Of Its Past
Your Own Worst Enemy: How To Prevent Ego From Destroying Your Portfolio
Cellular Dynamics: A Speculative Life Sciences Company Worth Getting To Know
Alcobra: A Speculative Biopharmaceutical Company With An Intriguing ADHD Drug Candidate
Paragon Shipping: Improving Fundamentals And Exemplary Leadership Point To Significant Upside
WidePoint: An Undervalued Provider Of Information Technology Solutions
Xencor: A Speculative Biopharmaceutical Company Employing Groundbreaking Science